Delivery Order SPE2DR25D1202-SPE2DR26F73HJ
- Not listed
- The Defense Logistics Agency awarded a $69,283.76 delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $23,553.20 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $14,720.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Xeomin 100 Unit Vials, with an ultimate completion date of December 23, 2025. This competitive award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xeomin 100 unit vials valued at $6,704.88 with a firm fixed price structure. The order is scheduled for completion by August 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $11,531.52 delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 50 Unit Vials, with a completion date of December 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single delivery order draw against AmerisourceBergen's larger contract vehicle with DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 Unit Vials with a ceiling value of $35,535.50 under a firm fixed-price contract. This non-set-aside award is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded procurement action sourced through the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 100 unit vials, valued at $23,467.08, with an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $19,569.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 3, 2025, for the supply of Xeomin 100 Unit Vials, with completion required by January 27, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $11,733.54 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials, with a completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor to the federal government,...
- The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used for neurological and aesthetic applications. This firm fixed price, non-set-aside contract was awarded on October 27, 2025, with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73HJDelivery Order
The Defense Logistics Agency awarded a $74,192.16 delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with an ultimate completion date of January 13, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare systems worldwide. The Xeomin procurement supports the Defense Health Agency and other federal healthcare operations, with the supply chain managed through DLA's medical procurement framework designed to provide critical pharmaceutical products to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.2k | 12/18/25 |